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Abstract
Background—The Apolipoprotein E (APOE) gene encodes for three isoforms in the human 
population (APOE2, APOE3, and APOE4). While the role of APOE in lipid metabolism is well 
characterized, the specific metabolic signatures of the APOE isoforms, during metabolic disorders, 
remain unclear.
Objective—To elucidate the molecular underpinnings of APOE-directed metabolic alterations, 
we tested the hypothesis that APOE4 drives a whole-body metabolic shift toward increased lipid 
oxidation.
Methods—We employed humanized mice in which Apoe gene has been replaced by the human 
APOE*3 or APOE*4 allele to produce human APOE3 or APOE4 proteins and characterized 
several mechanisms of fatty acid oxidation, lipid storage, substrate utilization and thermogenesis 
in those mice.
Results—We show that while APOE4 mice gained less body weight and mass than their APOE3 
counterparts on a Western-type diet (p<0.001), they displayed elevated insulin and HOMA, 
markers of insulin resistance (p=0.004 and p=0.025, respectively). APOE4 mice also demonstrated 
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a reduced respiratory quotient during the postprandial period (0.95±0.03 vs. 1.06±0.03, p<0.001), 
indicating increased usage of lipids as opposed to carbohydrates as a fuel source. Finally, APOE4 
mice showed increased body temperature (37.30 ± 0.68 vs 36.9 ± 0.58 °C, p=0.039), augmented 
cold tolerance, and more metabolically active brown adipose tissue compared to APOE3 mice.
Conclusion—These data suggest that APOE4 mice may resist weight gain via an APOE4-
directed global metabolic shift toward lipid oxidation and enhanced thermogenesis, and may 
represent a critical first step in the development of APOE-directed therapies for a large percentage 
of the population affected by disorders with established links to APOE and metabolism.
INTRODUCTION
Apolipoprotein E (APOE) associates with lipoproteins and mediates their receptor binding, 
thereby playing a paramount role in lipid metabolism. In humans, the APOE gene is 
polymorphic and has three alleles, APO*E2, *E3, and *E4 1. A wealth of studies show that 
plasma lipids are higher in individuals who carry an APOE*4 allele (15–20% of the 
population) when compared to individuals with only APOE*3 alleles 2. In addition to 
hyperlipidemia, APOE*4 has also been linked to metabolic syndrome (MetS) and impaired 
ability to properly manage postprandial glucose and carbohydrates 3–5. Interestingly, 
impaired glucose metabolism in the brain is a hallmark of Alzheimer's disease (AD) 6, and 
the APOE*4 allele is associated with reduced neuronal glucose utilization 7 and increased 
risk of developing AD 8.
Obesity, defined as a pathological expansion of white adipose tissue (WAT), is associated 
with higher levels of fasting insulin and glucose in plasma 9. In addition to its lipid-storing 
capacity, adipose tissue represents a highly active endocrine and metabolic organ 10. The 
presence of a dysfunctional adipose depot is a metabolic complication that increases the risk 
of developing insulin resistance (IR), MetS and type 2 diabetes (T2D), and is closely linked 
to disturbances in lipid and glucose metabolism11.
We have previously provided evidence in mice 12,13 and humans 5,14 suggesting that APOE 
plays an important role in WAT function. However, the specific metabolic signatures of the 
APOE isoforms – and their pathophysiologycal contributions during obesity – remain 
unclear. Given the current epidemic of obesity, elucidating the molecular underpinnings of 
APOE-directed metabolic alterations has become a critical step toward development of 
targeted therapies for disorders ranging from MetS to AD.
In the current study we employed humanized mice in which Apoe gene has been replaced by 
the human APOE*3 or APOE*4 allele to produce human APOE3 or APOE4 proteins at 
physiological levels 15. We aimed to characterize the energy balance phenotype of these 
mice with human APOE in regards to weight gain, body composition, adipose tissue 
physiology, glucose homeostasis, energy utilization, and thermogenesis. Here, we show that 
when compared to mice with APOE3, the presence of APOE4 in mice alters the global 
metabolic profile with a shift toward fatty acid oxidation and increased BAT-mediated 
thermogenesis.
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MATERIAL AND METHODS
Mice
Mice homozygous for replacement of the endogenous Apoe gene with the human APOE*3 
(APOE3) or APOE*4 (APOE4) allele were backcrossed onto a C57BL/6 genetic 
background 15. Leptin deficient (ob/ob) mice on a C57BL/6 genetic background were 
purchased from Jackson laboratories (B6.Cg-Lepob/J) (Jackson Labs, Bar Harbor, ME, 
USA). Mice heterozygous for leptin deficiency (ob/+) were crossed to human APOE mice 
and bred to produce mice homozygous for leptin deficiency (ob/ob) and homozygous for 
human APOE. Male mice were fed ad libitum either regular chow containing 5.3% fat and 
0.019% cholesterol (Prolab Isopro RMH 3000, ref 5P76; Agway Inc., Syracuse, NY, USA) 
or a high-fat Western-type diet (WD) containing 21% (w/w) fat and 0.2% (w/w) cholesterol 
(TD88137; Teklad, Madison, WI, USA) over the period indicated in each experiment. All 
procedures complied with the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals and with IACUC approval at the University of North Carolina and at 
Oregon Health & Sciences University.
Indirect Calorimetry
Mice were housed in a comprehensive lab animal monitoring system (CLAMS) (Columbus 
Instruments International Corporation, Columbus, Ohio, USA). Following a 24 hour 
acclimation period, mice were monitored for 24 hours for O2 consumption, CO2 production, 
and Respiratory Exchange Ratio, RER (RER = vCO2/vO2, where v is volume). Mice were 
fed ad libitum regular chow. Horizontal and vertical activity was determined by counting the 
number of successive beam breaks over 15 minutes using infrared photo beams.
Biochemical and Metabolic Assays
After a 4-h fast, animals were anesthetized with 2,2,2-tribromoethanol and blood was 
collected. Plasma glucose, cholesterol, free fatty acids (FFAs), and total ketone bodies were 
measured using commercial kits (Wako, Richmond, VA, USA). Triglycerides (TG), insulin 
and lactate were determined using commercial kits from Stanbio (Boerne, TX, USA), 
Crystal Chem Inc. (Downers Grove, IL, USA) and Sigma-Aldrich (St. Louis, MO, USA), 
respectively. Feces were freeze-dried and mechanically homogenized and fecal TG 
determined as above. Protein expression levels were analyzed by Western blot using 
antibodies against UCP1(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 
Adiponectin (Sigma-Aldrich). Temperatures of mice were taken with a rectal thermometer 
(Thermoworks, American Fork, UT, USA) between 3:00 and 4:00 PM. For cold tolerance 
tests, fasted mice were individually placed in cages at 7°C and body temperatures were 
taken every 60 minutes.
Fat Explants
Subcutaneous inguinal and visceral epididymal adipose tissues were cut with scissors into 
small pieces (20–40 mg) under aseptic conditions and incubated in high glucose Dulbecco's 
modified Eagle's medium (Sigma-Aldrich) with or without insulin (Sigma-Aldrich). After 24 
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h, glucose reduction in the medium was measured and the result was normalized according 
to fat weight.
Glucose Uptake
Mice were injected following a four-hour fast with 0.75 μCi of 2-[1,2-3H (N)]-Deoxy-D-
glucose (Perkin Elmer, Boston MA, USA), diluted in 100 μl of 0.25 g/ml glucose solution, 
via the tail vein. Twenty minutes after injection mice were euthanized, intracardially 
perfused with Phosphate-Buffered Saline (PBS), and tissues were collected. Tissue 
homogenates were transferred to a scintillation vial with 1 ml of Optiphase scintillation fluid 
(Perkin Elmer), and samples were analyzed using a liquid scintillation counter (Beckman 
Coulter, Brea, CA, USA).
Gene Expression
RNA was isolated with TRIzol Reagent (Sigma-Aldrich) according to the manufacturer 
instructions and followed by a DNAse treatment (Applied Biosystems, Foster City, CA, 
USA). Retrotranscription was performed according to the High capacity cDNA 
retrotranscription kit instructions (Applied Biosystems). Real Time PCR was carried out 
with the SYBERgreen I enzyme (Applied Biosystems) in a StepOnePlus thermocyler 
(Applied Biosystems). β-Actin mRNA was used for normalization.
Statistical Analysis
Data are expressed as mean ± standard error. Multiple groups were compared using 2-way 
ANOVA, with genotype (APOE3 vs. APOE4) and diet (standard diet vs. westernized high 
fat diet) as main factors. The level of significance was set at 0.05. Data were analyzed using 
R version 3.1.3 (http://www.r-project.org) and figures generated with GraphPad prism v.5.0 
(San Diego, CA, USA).
RESULTS
APOE4 Mice Gain Less Body Weight and Visceral Fat When Fed an Obesogenic Diet
We have previously described that when fed an obesogenic diet there is a less pronounced 
increase in body weight of young APOE4 mice, compared to APOE3 mice 12. To determine 
whether this difference was sustained in older age, we modeled diet-induced obesity (DIO) 
in APOE3 and APOE4 mice through chronic administration of a Western-type diet from 2 
until 12 months of age. Cohorts of mice were euthanized after either 1, 2, 6 or 10 months on 
the obesogenic diet and body weight and adipose tissue mass were measured. During the 
obesogenic feeding both groups of mice increased their body weight (p<0.0001 diet effect, 
2-way ANOVA) (Fig. 1A). Compared to DIO-APOE3, DIO-APOE4 mice were consistently 
leaner throughout the diet (p<0.001 genotype effect, 2-way ANOVA). DIO-APOE4 mice 
also had decreased epididymal fat pad mass relative to DIO-APOE3 mice (p=0.05 genotype 
effect, 2-way ANOVA) (Figure 1B).
To determine whether the lower body weight and visceral fat mass in APOE4 mice were due 
to decreased caloric intake or lipid malabsorption, we measured daily food intake and 
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steatorrhea. However, no differences in fecal lipid excretion or daily food consumption were 
observed between genotypes (not shown).
Genetically Obese Mice Carrying APOE4 Show Reduced Weight Gain
We next asked whether this phenomenon of blunted weight gain in APOE4 mice was 
specific to a Western-type diet, or if it would be replicated in a genetic model of obesity. 
Therefore, we employed the commonly used leptin deficient mice and intercrossed them 
with APOE3 and APOE4 mice to obtain mice homozygous for either the APOE3 or APOE4 
allele and simultaneously homozygous for the leptin mutation (ob/ob). Similar to their DIO 
counterparts, APOE4-ob/ob mice weighed significantly less than the APOE3-ob/ob mice at 
4 months of age (Figure 1C; p=0.025, t-test). APOE4-ob/ob mice also showed ~20% less 
adipose tissue accumulation compared to APOE3-ob/ob mice when measured by DEXA 
(Figure 1D; p=0.044, t-test)
Plasma Markers of Insulin Resistance and Fatty Acid Utilization are Elevated in Obese 
APOE4 Mice
Plasma cholesterol and triglycerides increased similarly over the course of the obesogenic 
diet in both DIO-APOE3 and DIO-APOE4 mice (Table 1) (p<0.001 for the diet effect, 2-
way ANOVA). Plasma glucose values remained unchanged during the diet administration 
for both DIO-APOE3 and DIO-APOE4 mice. However, using a 2-way ANOVA model, there 
was an overall effect of APOE4 genotype on both plasma insulin and the homeostatic model 
assessment (HOMA), used to quantify insulin resistance (IR), as both measures were 
significantly increased in DIO-APOE4 mice (Table 1, p=0.004 and p=0.025, respectively).
Throughout the diet administration, plasma lactate, a marker of anaerobic glycolysis, was 
consistently higher in DIO-APOE3 mice compared to DIO-APOE4 mice (Table 1) (p=0.03 
genotype effect, 2-way ANOVA). Concurrently, while markers of stimulated fatty acid 
oxidation, such as total ketone bodies and adiponectin increased in both genotypes over the 
course of the diet administration, these markers were significantly higher in DIO-APOE4 
compared to DIO-APOE3 mice (Table 1) (p=0.01 and p=0.005 genotype effect, ketone 
bodies and adiponectin, respectively; 2-way ANOVA).
To investigate whether adiponectin oligomer composition, in addition to total plasma 
adiponectin levels, differed between genotypes, plasma from DIO-APOE3 and DIO-APOE4 
mice was subjected to non-reducing sodium dodecyl sulfate (SDS)-polyacrylamide gel 
electrophoresis. No differences in the medium molecular weight (MMW) oligomer were 
found between genotypes (Figure 1E). However, DIO-APOE4 mice demonstrated a ~60% 
increased high-molecular weight (HMW) oligomer concentration compared to DIO-APOE3 
mice (p=0.04, t-test)(Figure 1E-F). Increased HMW oligomer translated into a higher 
HMW/MMW ratio than their DIO-APOE3 counterparts (0.94±0.07 vs. 0.54±0.04, 
respectively; p<0.001, t-test).
The genetically obese APOE3-ob/ob and APOE4-ob/ob mice showed a similar metabolic 
profile to their DIO counterparts. A trend showing higher plasma glucose and adiponectin 
levels was noted in the APOE4-ob/ob compared to APOE3-ob/ob mice (Supplementary 
Table (p=0.08 for both determinations, t-test). The ob/ob model is characterized by severe 
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fatty liver. However, this fat accumulation showed a genotype effect and a ~60% increase in 
hepatic triglycerides was detected in APOE4-ob/ob when compared to their APOE3-ob/ob 
counterparts (p=0.038, t-test). Together, these results suggest that APOE4 mice are more 
susceptible to obesity-induced complications (IR and fatty liver) and demonstrate an 
increased reliance on fatty acid consumption.
APOE4 Mice Show a Decreased Usage of Carbohydrates Compared to
We next assessed the effect of APOE on whole-body metabolic rates by measuring oxygen 
consumption and respiratory exchange rate ( using indirect To clearly distinguish between 
pre-existing APOE effects versus those specific to the obese state, we assayed 1) APOE3-
ob/ob and APOE4-ob/ob mice with body weights of (61.6±2.2 and 52.3±2.6, respectively, 
p=0.025) and 2) standard chow-fed APOE3 and APOE4 mice without the ob mutation, with 
body weights of (26.7±0.5 and 24.6±0.5 g, respectively, p=0.007). Figure 2 shows the 
expected circadian RER fluctuations in standard chow-fed mice, with lower values of during 
fasting period (light), indicating an increased utilization of lipids as fuel. RER increased in 
both genotypes during the dark period, which is when mice consume most of their daily 
food. However, this increase was genotype-dependent as APOE4 mice had significantly 
lower mean RERs during this period compared to APOE3 mice (0.95±0.03 vs. 1.06±0.03, 
p<0.001, t-test). A similar genotype effect was observed in the DIO-APOE3 and DIO-
APOE4 mice (not shown) as well as in the genetically obese mice (Supplementary Figure 1). 
APOE4-ob/ob mice had a mean RER of 0.92±0.02 vs. 1.00± 0.02 in APOE3 mice (p<0.001, 
t-test).
Physical activity may increase fat oxidation and reduce RER. However, the observed 
locomotor activity in both groups was similar throughout the experiment (Figure 2, insets), 
and both groups exhibited clear diurnal activity patterns. Likewise, total oxygen 
consumption, reflective of total metabolic activity, did not differ between APOE3 and 
APOE4 mice in either background (data not shown). Together, these data suggest that both 
lean and obese mice with APOE4 show a preference toward a decreased usage of 
carbohydrates compared to those with APOE3.
APOE4 Mice Have Increased Basal Temperature and Augmented Cold Tolerance
Previous studies have established a link between increased fatty-acid oxidation and 
stimulation of thermogenesis 16. Interestingly, we observed a significant increase in basal 
core temperatures in standard chow-fed APOE4, compared with APOE3 mice (37.30 ± 0.68 
vs 36.9 ± 0.58 °C, respectively;n=25-33, p=0.039, t-test). We then subjected mice to a long-
term (10 hour) cold tolerance and APOE4 mice were able to maintain a significantly higher 
core body temperature compared to APOE3 mice (Figure 3A) (p<0.05 genotype effect, 
repeated-measures ANOVA).
Upon stimulation, BAT cells degrade intracellular TG to release fatty acids which interact 
with uncoupling protein-1 (UCP1), thereby leading to uncoupled mitochondrial respiration 
and the generation of heat 17. Therefore, we assessed several markers of fatty acid 
metabolism before and after the cold tolerance test. We observed reductions in body weight 
during the cold exposure, and strikingly this weight loss was almost double in APOE4 
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compared to APOE3 mice (Figure 3B) (11.1 vs. 6.7 % of their initial body weight 
respectively, p<0.). As previously observed, plasma adiponectin was significantly higher in 
APOE4 compared to APOE3 mice (Figure 3C) ( p<0.001, APOE effect, 2-way ANOVA), 
but no response to the cold was observed. Non-esterified fatty acid (NEFA) and total ketone 
bodies levels rose in both genotypes during cold exposure (Figure 3E-F) (p<0.001 for the 
time effect in both variables, 2-way ANOVA). However, while higher values of both NEFA 
and total ketone bodies were seen in the APOE4 compared to APOE3 mice following the 
cold tolerance test, this difference only reached significance for ketone bodies (p=0.002, 
time effect, 2-way ANOVA).
We next determined NEFA release in vitro in visceral and subcutaneous WAT explants 
extracted from standard chow-fed APOE3 and APOE4 mice. NEFA release ex vivo from 
APOE4 explants was higher than that of APOE3 explants, although this lipolytic effect was 
only significant in visceral WAT. (Figure 3F) (p=0.090 and p=0.046 for subcutaneous and 
visceral respectively, t-test).
Together, these data suggest that APOE4 mice are more thermogenically active than their 
APOE3 counterparts, and that this phenomenon may be due to enhanced release of fatty 
acids from the visceral fat.
BAT in APOE4 Mice is More Metabolically and Thermogenically Active
Cold-induced thermogenesis in vivo is mediated through BAT activation. Likewise, 
overfeeding as occurs with a WD is accompanied by increased thermogenesis to dissipate 
energy as a homeostatic mechanism against excess energy intake 17. Therefore, we 
examined metabolic activity and thermogenic gene expression within the BAT of APOE3, 
APOE4, DIO-APOE3, and DIO-APOE4 mice. Compared to APOE3 and APOE4 mice, both 
DIO-APOE3 and DIO-APOE4 mice showed increased interscapular BAT mass (149 ± 16 vs. 
82 ± 6 mg for APOE3 mice and 151 ± 17 vs. 101 ± 13 mg for APOE4, p<0.01, diet effect, 
2-way ANOVA).
To assess the general metabolic activity of BAT, mice were intravenously administered a 
bolus of 2-[1,2-3H (N)]-Deoxy-D-glucose (2-DG). 2-DG uptake in standard diet-fed mice 
was approximately twice as high as in DIO-mice in both white adipose (subcutaneous and 
visceral) and interscapular BAT. Specifically, standard diet-fed APOE3 and APOE4 mice 
took up twice as much 2-DG in their BAT as did DIO-E3 and DIO-E4 mice (99.9±8.4 vs. 
40.3 ± 4.1 and 138.9 ± 12.2 vs 74.5 ± 6.6 CPM/g, respectively; p<0.001 for diet effect, 2-
way ANOVA). While no genotype differences in 2-DG uptake were observed in the white 
adipose tissue depots, BAT from both APOE4 and DIO-APOE4 mice demonstrated 
significantly higher rates of 2-DG uptake compared with BAT from their APOE3 
counterparts (Figure 4A)(p<0.001, genotype effect; 2-way ANOVA). No genotype 
differences in 2-DG uptake were observed in the white adipose tissue.
We next examined the expression of several genes known to be master regulators of 
metabolic homeostasis. Coincident with the observed metabolic pattern, mRNA levels of 
PPARand PDK4 genes appeared upregulated in the skeletal muscle of DIO-APOE4 mice 
when compared to their DIO-APOE3 counterparts (p=0.09 and p=0.03, respectively, t-test) 
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(Figure 4B). On the contrary, those genes related to muscular glucose uptake (GLUT4) and 
insulin sensitivity (IRS1 and IRS2) showed decreased expression in DIO-APOE4, although 
only the latter reached statistical significance (p=0.02, t-test). Subsequently, metabolic 
regulators were also investigated in BAT. We noted a pattern of increased mRNA levels of 
several regulators of mitochondrial biogenesis, fatty acid oxidation and glucose uptake 
(Figure 4C). BAT from APOE4 mice showed higher expression of PGC1A, PRDM16, 
ADIPOR1, ADIPOR2, and UCP1, although this only reached significance for PGC1A, 
ADIPOR2, and UCP1 (p=0.02, p=0.04 and p=0.04, respectively; t-test). Finally, given the 
crucial role of UCP1 in thermogenesis, we measured UCP1 protein levels within the BAT of 
APOE3 and APOE4 mice. When compared to DIO-APOE3 mice, UCP1 protein expression 
was significantly higher in the BAT of DIO-APOE4 mice (Figure 5D) (p=0.01, t-test). Taken 
together, these data suggest that the APOE*4 allele is associated with an increase in the 
metabolic and thermogenic activity of BAT.
DISCUSSION
The polymorphic apolipoprotein E (APOE) plays significant roles in the delivery of lipids to 
target tissues 15. However, beyond its functions in lipoprotein metabolism, research on the 
specific role of the APOE isoforms in energy balance is scarce. In this study, we show that 
mice carrying the human APOE*4 allele have a distinct metabolic profile compared to mice 
with the APOE*3 allele. Specifically, this APOE*4-specific profile is characterized by 
reductions in weight gain and visceral fat, a shift toward fatty acid oxidation, and more 
metabolically and thermogenically active BAT.
Obesity has reached epidemic rates worldwide 18, and the frequency of APOE*4 carriers 
(~25% of the population) is relatively high. Although some studies have failed to observe an 
impact of APOE genotype on body weight 19,20, we and others have reported an association 
of the APOE isoforms with body mass index (BMI) in the order of APOE4 < APOE3 < 
APOE2 14,21. Likewise, our previous research has shown that, similar to humans, mice 
expressing human APOE4 gain less body weight and adipose tissue than mice with APOE3 
when fed a Western-type diet 12. While decreased fat mass traditionally carries positive 
connotations, the reduced adipogenesis in APOE4 mice, as well as APOE*4 carrying 
humans, appears to be detrimental. The failure to store lipids in adipose tissue is a potential 
contributor to obesity-induced IR and glucose intolerance among APOE4 carriers, both in 
mice 12 and humans 5. In the current study, we confirm and expand upon these APOE effects 
on adiposity and glucose metabolism in diet-induced and genetic models of obesity, as both 
DIO- and ob/ob-APOE3 mice increased their WAT mass and maintained enhanced insulin 
sensitivity compared to their APOE4 counterparts.
In the case of defective adipose tissue expansion, more FFA are typically released into the 
circulation to be taken up by skeletal muscle and thermogenic tissues such as BAT where 
they serve as a fuel 22. Excess fatty acids are also channeled to the liver for the generation of 
ketone bodies 23. Incidentally, we have previously shown impaired adipogenesis and 
increased steatosis in APOE4 mice with diet-induced obesity 13. Recently, a higher 
expression of proteins involved in lipid oxidation in skeletal muscle accompanied by 
activation in adipose tissue lipase has been also described in APOE4 mice 24. This report 
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extends these studies by showing that these phenomena should be interpreted in conjunction 
with an overall change in the pattern of fuel consumption. RER values reflect global fuel 
substrate utilization, and typically, a RER of ~0.70 indicates that fat is the predominant fuel 
source, while a RER close to 1.00 indicates carbohydrates 25. The observed mean RER value 
in APOE3 mice (1.06) is likely associated with a high rate of glucose utilization and 
conversion into lipid, as RERs surpassing 1.0 typically only appear when glucose is 
channeled to de novo lipogenesis 26. Consistent with this, APOE3 mice accumulated more 
white adipose tissue and showed increased body weight than APOE4 mice.
Furthermore, the shift toward lipid utilization in APOE4 mice noted above was accompanied 
by several metabolic features that point toward increased fatty acid oxidation. This included 
increased ex vivo fatty acid release by adipose tissue, higher basal body temperature, 
augmented cold tolerance, and increased glucose uptake and thermogenic gene and protein 
expression in BAT. Interestingly, reactive oxygen species (ROS) are generated during fatty 
acid oxidation causing IR 27, and APOE4 has itself been associated with increased oxidative 
stress [Reviewed in 28]. Likewise, previous reports show that uncoupling is a physiologically 
relevant mechanism to reduce oxidative stress in a mammalian organ of high oxidative 
capacity 29. Thus, a potential hypothesis to link the thermogenic and metabolic profiles 
associated with APOE4 is that stimulation of lipid oxidation in APOE4 mice might increase 
the ROS demand for antioxidant measures as cellular oxygen increases – thereby creating a 
thermoregulatory effect through UCP1 activation and heat production – which may, at least 
partially, increase body temperature and cold tolerance.
The phenomena described above appear to be leptin-independent, as similar phenotypes 
were observed in both wild type and leptin-deficient (ob/ob) human APOE mice. On the 
other hand, elevations in total adiponectin and in particular its most active high molecular 
weight multimer, were observed in APOE4 mice. Some studies have previously reported that 
adiponectin inhibits thermogenesis and UCP1 expression via a reduction in the supply of 
fatty acids to be used as thermogenic substrates 30,31. In this study, we show that the 
presence of APOE4 is associated with increases in the percentage of lipid diverted to 
oxidation. This catabolic process releases NEFA from WAT, which can be directed to the 
BAT to feed, at least partially, the thermogenic process, thereby offsetting the possible 
inhibitory effects of adiponectin 16. Moreover, increased expression of adiponectin 
receptors, which are positive regulators of UCP1 32, was measured in the BAT of APOE4 
mice. It has been proposed that adiponectin receptors may have other ligands or have ligand-
independent activity 31. Thus, the observed rise in adiponectin could simply be a 
consequence of reduced WAT mass, and may not be directly involved in the regulation of the 
metabolic switch observed in APOE4 mice
This APOE4 shift, or preference, toward fatty acid rather than carbohydrate oxidation 
reported in this study has implications for a number of disease states in which APOE plays a 
role, including obesity, diabetes, cardiovascular disease (CVD), and AD 33. Although this 
study focused on adipose tissues and whole body fuel utilization, our results may have 
particularly important implications for neurodegenerative disease, specifically AD. APOE4 
genotype represents the most significant genetic risk factor for late onset AD 34,35. 
Moreover, obesity and IR predispose individuals to cognitive impairments and an increased 
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risk of developing dementia 36, and this association is remarkably strong among carriers of 
the APOE*4 allele 37. Furthermore, patients with AD demonstrate a functional brain IR 6, 
while APOE4 itself has also been associated with inefficient brain glucose regulation 38, 
even decades prior to onset of disease 7, suggesting that APOE4 and IR may involve shared 
neuropathological pathways. Interestingly, increased plasma adiponectin levels, as observed 
in APOE4 carriers, are an independent risk factor for the development of both all-causes of 
dementia in men and women and of AD in women 39. The brain relies primarily on glucose 
as an energy source, and thus an inherent metabolic preference toward usage of fats vs 
carbohydrates could represent a critical handicap for APOE4-expressing neurons and glia.
In summary, the presence of APOE4 changes the global metabolic profile with a shift toward 
fatty acid oxidation and increased thermogenesis in mice. As BAT mass is minimal in adult 
humans relative to WAT, further clarifying in humans the metabolic differences observed in 
this study is warranted. Understanding the role of APOE in metabolism may represent a 
critical first step in the development of APOE-directed therapies for a large percentage of the 
population affected by obesity, diabetes, age-related cognitive decline, AD, and CVD.
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Figure 1. 
Two-month old APOE3 and APOE4 mice were fed a Western-type diet and euthanized after 
different periods on the diet (n=5 for each genotype at any given time point), then total body 
weight (A) and gonadal adipose mass (B) were measured. # p=0.05, ## p<0.001 for WD-
APOE3 vs WD-APOE4, $ p<0.001 time on diet, 2-way ANOVA. Similarly, APOE3-ob/ob 
and APOE4-ob/ob mice (n = 5 for each genotype) were weaned and fed for 3 months a 
standard laboratory diet and body weight (C), as well as total fat mass measured by DEXA 
(D) were determined. n = 6 mice/genotype. *p<0.05, **p<0.01, t-test. Plasma adiponectin 
levels in APOE3 and APOE4 mice fed a Western-type diet for 2 months was analyzed by 
non-denaturing SDS-PAGE into its medium molecular weight (MMW) and higher molecular 
weight (HMW) fractions (A). A representative profile is shown in (B) with the ratio (HMW/
MMW) between fractions. (n=8 per genotype). *p<0.05, t-test.
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Figure 2. 
Two-month old APOE3 and APOE4 mice fed standard laboratory chow were individually 
housed in a comprehensive lab animal monitoring system (CLAMS) and allowed to a 24-
hour acclimation period.
Respiratory Exchange Ratio, RER (Upper panel). p<0.001 for differences between APOE3 
and APOE4 and p<0.001 for light vs. dark, 2-way ANOVA. Locomotor Activity was 
recorded as the number of successive infrared beam breaks in 15 min time binds. (Lower 
panel) during 24 hours. Inset shows the average Locomotor Activity per individual mouse.
Lighting regimes are represented by bars above each graph (solid bars denote dark phase, 
and open bars denote light phase). Values are expressed as the group mean ± SEM ; n = 8 for 
each genotype.
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Figure 3. 
Fasting mice were individually housed at at 7°C for up to 10 h and core temperature was 
measured hourly with a rectal probe, ¶ p<0.05 genotype effect, repeated-measures ANOVA. 
(A). Percentage of body weight lost (B) and plasma NEFA (C), adiponectin (E), and the 
ketone body β-hydroxybutyrate (F) were determined at the begining (0 h) and at the end (10 
h) of the cold challenge. Averaged data from 2 different cohorts of APOE3 (white bars) and 
APOE4 (black bars) mice are presented as mean ± SEM ; n = 8 mice for each genotype and 
cohort . # p<0.001 for APOE3 vs. APOE4, $ p<0.001 for standard vs. obesogenic diet, 2-
way ANOVA. * p < 0.05, t-test
Release of NEFA into the medium by explants of subcutaneous inguinal (SC) and 
epididymal visceral (VIS) fat over 24 h at 37 °C (E). NEFA release was measured as 
described in Methods. Results are micromoles of NEFA released by milligram of tissue 
protein. Each column represents the mean ± SEM for 5 mice. * p < 0.05, t-test
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Figure 4. 
Glucose uptake was measured in APOE3, APOE4, DIO-APOE3 and DIO-APOE4 mice. 
Mice were fed a standard laboratory chow or an obesogenic diet (DIO) for six months. 
Following a four hour fast, mice were given an intravenous bolus of 2-[1,2-3H (N)]-Deoxy-
D-glucose and its accumulation was measured in subcutaneous (SC) and visceral (Vis) white 
adipose depots (WAT) as well as intrascapular (IS) brown adipose tissue (BAT). (# p<0.001 
for APOE3 vs. APOE4, $ p<0.001 for standard vs. obesogenic diet, 2-way ANOVA)(A). 
Effects of APOE allele and feeding on expression of representative genes in the 
gastrocnemius skeletal muscle (B) and intrascapular BAT (C). UCP1 protein expression in 
BAT as determined by immunoblot assay. Protein loading was evaluated by Ponceau S 
staining (D).* p<0.05, **p<0.01 for the difference between APOE3 and APOE4, t-test.
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